197 related articles for article (PubMed ID: 33453141)
1. Relationship between QT interval prolongation and structural abnormalities in cirrhotic cardiomyopathy: A change in the current paradigm.
Koshy AN; Gow PJ; Testro A; Teh AW; Ko J; Lim HS; Han HC; Weinberg L; VanWagner LB; Farouque O
Am J Transplant; 2021 Jun; 21(6):2240-2245. PubMed ID: 33453141
[TBL] [Abstract][Full Text] [Related]
2. Effect of liver transplantation on QT-interval prolongation and impact on mortality.
Ko J; Koshy AN; Han HC; Weinberg L; Gow P; Testro A; Lim HS; Farouque O; Teh AW
Int J Cardiol; 2021 Mar; 326():158-163. PubMed ID: 33186663
[TBL] [Abstract][Full Text] [Related]
3. QT interval prolongation and decreased heart rate variability in cirrhotic patients: relevance of hepatic venous pressure gradient and serum calcium.
Genovesi S; Prata Pizzala DM; Pozzi M; Ratti L; Milanese M; Pieruzzi F; Vincenti A; Stella A; Mancia G; Stramba-Badiale M
Clin Sci (Lond); 2009 May; 116(12):851-9. PubMed ID: 19076059
[TBL] [Abstract][Full Text] [Related]
4. Impact and persistence of cirrhotic cardiomyopathy after liver transplantation.
Sonny A; Ibrahim A; Schuster A; Jaber WA; Cywinski JB
Clin Transplant; 2016 Sep; 30(9):986-93. PubMed ID: 27292629
[TBL] [Abstract][Full Text] [Related]
5. Corrected QT interval and QT dispersion in cirrhotic patients before and after liver transplantation.
Zamirian M; Tavassoli M; Aghasadeghi K
Arch Iran Med; 2012 Jun; 15(6):375-7. PubMed ID: 22642249
[TBL] [Abstract][Full Text] [Related]
6. [Cirrhotic cardiomyopathy].
Kasper P; Steffen HM; Michels G
Dtsch Med Wochenschr; 2021 Aug; 146(16):1070-1076. PubMed ID: 34416775
[TBL] [Abstract][Full Text] [Related]
7. Prolonged QT Interval in Cirrhosis: Twisting Time?
Lee W; Vandenberk B; Raj SR; Lee SS
Gut Liver; 2022 Nov; 16(6):849-860. PubMed ID: 35864808
[TBL] [Abstract][Full Text] [Related]
8. Cirrhotic cardiomyopathy: Isn't stress evaluation always required for the diagnosis?
Barbosa M; Guardado J; Marinho C; Rosa B; Quelhas I; Lourenço A; Cotter J
World J Hepatol; 2016 Jan; 8(3):200-6. PubMed ID: 26839643
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and clinical presentation of cirrhotic cardiomyopathy: A single centre experience from southern India.
Bokarvadia R; Jain M; Kedarisetty C; Varghese J; Venkataraman J
Indian J Gastroenterol; 2019 Apr; 38(2):150-157. PubMed ID: 31115783
[TBL] [Abstract][Full Text] [Related]
10. Cirrhotic cardiomyopathy: a cardiologist's perspective.
Gassanov N; Caglayan E; Semmo N; Massenkeil G; Er F
World J Gastroenterol; 2014 Nov; 20(42):15492-8. PubMed ID: 25400434
[TBL] [Abstract][Full Text] [Related]
11. Protective role of cardiac-specific overexpression of caveolin-3 in cirrhotic cardiomyopathy.
Kim SY; Kim KH; Schilling JM; Leem J; Dhanani M; Head BP; Roth DM; Zemljic-Harpf AE; Patel HH
Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G531-G541. PubMed ID: 31961720
[TBL] [Abstract][Full Text] [Related]
12. Propranolol can correct prolonged QT intervals in patients with cirrhosis.
Han H; Chen J; Deng Z; Li T; Qi X; Deng W; Wu Z; Xiao C; Zheng W; Du Y
Front Pharmacol; 2024; 15():1370261. PubMed ID: 38738176
[TBL] [Abstract][Full Text] [Related]
13. Prolongation of QTc interval: relationship with etiology and severity of liver disease, mortality and liver transplantation.
Bal JS; Thuluvath PJ
Liver Int; 2003 Aug; 23(4):243-8. PubMed ID: 12895263
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis and Management of Cirrhotic Cardiomyopathy.
Kaur H; Premkumar M
J Clin Exp Hepatol; 2022; 12(1):186-199. PubMed ID: 35068798
[TBL] [Abstract][Full Text] [Related]
15. Pretransplant increases in left ventricular volume and mass are associated with QT prolongation during pediatric liver transplantation.
Cho HS; Kim WJ; Lee BA; Cho J; Shin WJ; Hwang GS
Pediatr Transplant; 2018 Jun; ():e13237. PubMed ID: 29908011
[TBL] [Abstract][Full Text] [Related]
16. Effect of QT interval prolongation on cardiac arrest following liver transplantation and derivation of a risk index.
Koshy AN; Ko J; Farouque O; Cooray SD; Han HC; Cailes B; Gow PJ; Weinberg L; Testro A; Lim HS; Teh AW
Am J Transplant; 2021 Feb; 21(2):593-603. PubMed ID: 32530547
[TBL] [Abstract][Full Text] [Related]
17. Pediatric cirrhotic cardiomyopathy: Impact on liver transplant outcomes.
Junge N; Junge C; Schröder J; Pfister ED; Leiskau C; Hohmann D; Beerbaum P; Baumann U
Liver Transpl; 2018 Jun; 24(6):820-830. PubMed ID: 29637720
[TBL] [Abstract][Full Text] [Related]
18. Markedly prolonged QTc interval in end-stage liver disease and risk of 30-day cardiovascular event after liver transplant.
Kim KS; Kwon HM; Jung KW; Sang BH; Moon YJ; Kim B; Jun IG; Song JG; Hwang GS
J Gastroenterol Hepatol; 2021 Mar; 36(3):758-766. PubMed ID: 32804412
[TBL] [Abstract][Full Text] [Related]
19. Cirrhotic Cardiomyopathy: The Interplay Between Liver and Cardiac Muscle. How Does the Cardiovascular System React When the Liver is Diseased?
Dourakis SP; Geladari E; Geladari C; Vallianou N
Curr Cardiol Rev; 2021; 17(1):78-84. PubMed ID: 31072296
[TBL] [Abstract][Full Text] [Related]
20. The Impact of Cirrhosis and Prescription Medications on QTc Interval Before and After Liver Transplantation.
Santeusanio AD; Dunsky KG; Pan S; Schiano TD
J Pharm Pract; 2019 Feb; 32(1):48-53. PubMed ID: 29092657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
